Oct 14, 2026 · 29 min
Asilomar shows how scientists can slow a dangerous race
Wanna slow down AI? These biologists can help.
The episode tests whether AI leaders can trade individual advantage for enforceable safeguards when catastrophic risks outpace regulation.
- 1Recombinant DNA scientists paused promising research after recognizing that individual ambition could create collective danger.
- 2Asilomar turned scientific self-restraint into practical rules covering risk classification, containment, and laboratory biosecurity.
- 3The agreement worked because government funding gave the National Institutes of Health leverage, a tool AI companies may lack.
Don't miss
Janet Mertz explains that the moratorium damaged her career and cost her the chance to be first, but she still judged the sacrifice worthwhile.
The brief
AI leaders face a collective-action trap: each may fear catastrophic consequences, yet racing ahead remains rational unless competitors accept the same restraint.
In the 1970s, Janet Mertz’s recombinant DNA work raised fears of cancer, escaped organisms, bioweapons, and designer babies. Robert Pollack’s objection helped stop one dangerous experiment.
Paul Berg and other scientists called a moratorium, then gathered at Asilomar in 1975. The meeting nearly became a showcase for new research before lawyers made liability personal.
Scientists approved rules for risk classification, containment, and biosecurity, but the agreement depended on NIH enforcement through research funding—not goodwill alone.
The episode’s sharpest lesson is that collective safety requires losers: Mertz says the moratorium damaged her career, yet believes the sacrifice was worthwhile.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.